✦ LIBER ✦

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes

✍ Scribed by Polidori, David; Mari, Andrea; Ferrannini, Ele

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Efficacy and Safety of Canagliflozin, a

✍ Leiter, Lawrence A.; Cefalu, William T.; Niskanen, Leo; Xie, John; Millington, D 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 62 KB

Evaluation of vulvovaginal symptoms and

✍ Nyirjesy, Paul; Zhao, Yue; Ways, Kirk; Usiskin, Keith 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 129 KB

Canagliflozin (CANA), a Sodium Glucose C

✍ Yale, Jean-Francois; Bakris, George; Xi, Liwen; Figueroa, Kate; Wajs, Ewa; Usisk 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 79 KB

Efficacy and safety of twice-daily treat

✍ Qiu, Rong; Capuano, George; Meininger, Gary 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 162 KB

Effect of canagliflozin, a sodium glucos

✍ Nicolle, L.E.; Capuano, G.; Ways, K.; Usiskin, K. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 135 KB